Quantinno Capital Management’s Krystal Biotech KRYS Stock Holding History
Bought
Maintained
Sold
Other funds holding KRYS
Quantinno Capital Management's KRYS Position: Q3 2026 in Review
Quantinno Capital Management increased its Krystal Biotech (KRYS) stake by 41% in Q3 2026, buying an estimated $564K and bringing the position to 5,647 shares worth $1.88M. The position accounts for ﹤0.01% of the portfolio, ranked #2237.
Quantinno Capital Management first reported a position in KRYS in Q3 2025 and has held it in 5 quarters since. 442 funds tracked by Wall St. Rank hold KRYS as of Q3 2026.
- Quantinno Capital Management held 5,647 shares of Krystal Biotech worth $1.88M as of Q3 2026.
- Quantinno Capital Management bought 1,629 Krystal Biotech shares in Q3 2026, an estimated $564K.
- Krystal Biotech made up ﹤0.01% of Quantinno Capital Management's portfolio in Q3 2026, its #2237 holding.
- Quantinno Capital Management first reported a position in Krystal Biotech in Q3 2025 and has held it in 5 quarters since.
- 442 funds tracked by Wall St. Rank held Krystal Biotech as of Q3 2026.
Based on Quantinno Capital Management's 13F filing for Q3 2026, filed 13 Nov 2026.